Works matching IS 09024441 AND DT 2021 AND VI 106 AND IP 4

Results: 20

Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R‐Mini‐CYVE) regimen for patients with relapsed or refractory B‐cell non–Hodgkin's lymphoma not eligible for intensive chemotherapy.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 574, doi. 10.1111/ejh.13589
By:
- Abdayem, Pamela;
- Ibrahim, Nathalie;
- El Dakdouki, Yolla;
- Willekens, Christophe;
- Ghez, David;
- A. Rouche, Julia;
- Dartigues, Peggy;
- Desmaris, Romain;
- Danu, Alina;
- Rossignol, Julien;
- Lazarovici, Julien;
- Fermé, Christophe;
- Ribrag, Vincent;
- Michot, Jean M.
Publication type:
Article
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 563, doi. 10.1111/ejh.13588
By:
- Rampotas, Alexandros;
- Djebbari, Faouzi;
- Panitsas, Fotios;
- Lees, Charlotte;
- Tsagkaraki, Ismini;
- Gomes, Ana Rita;
- Prideaux, Steve;
- Chen, Lucia;
- Prodger, Catherine;
- Khera, Akhil;
- Gray, Nicola;
- Ellis, Lauren;
- Sangha, Gavinda;
- Lim, Wen Yuen;
- Eyre, Toby A.;
- Moore, Sally;
- Ramasamy, Karthik;
- Kothari, Jaimal
Publication type:
Article
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 555, doi. 10.1111/ejh.13586
By:
- Takakuwa, Teruhito;
- Yamamura, Ryosuke;
- Ohta, Kensuke;
- Kaneko, Hitomi;
- Imada, Kazunori;
- Nakaya, Aya;
- Fuchida, Shin‐ichi;
- Shibayama, Hirohiko;
- Matsuda, Mitsuhiro;
- Shimazu, Yutaka;
- Adachi, Yoko;
- Kosugi, Satoru;
- Uchiyama, Hitoji;
- Tanaka, Hirokazu;
- Hanamoto, Hitoshi;
- Shimura, Yuji;
- Kanda, Junya;
- Onda, Yoshiyuki;
- Uoshima, Nobuhiko;
- Yagi, Hideo
Publication type:
Article
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 546, doi. 10.1111/ejh.13585
By:
- Afram, Gabriel;
- Susek, Katharina Helene;
- Uttervall, Katarina;
- Wersäll, Johanna Dehlsen;
- Wagner, Arnika Kathleen;
- Luong, Vincent;
- Lund, Johan;
- Gahrton, Gösta;
- Alici, Evren;
- Nahi, Hareth
Publication type:
Article
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?—Potential therapeutic applications.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 589, doi. 10.1111/ejh.13584
By:
- Roché, Pauline;
- Venton, Geoffroy;
- Berda‐Haddad, Yaël;
- Fritz, Shirley;
- Ivanov, Vadim;
- Mercier, Cédric;
- Colle, Julien;
- Tichadou, Antoine;
- Fanciullino, Raphaëlle;
- Lepidi, Hubert;
- Costello, Régis;
- Farnault, Laure
Publication type:
Article
Late occurrence of progressive multifocal leukoencephalopathy after anti‐CD19 chimeric antigen receptor T‐cell therapy.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 584, doi. 10.1111/ejh.13583
By:
- Mian, Agrima;
- Andrapalliyal, Nirmal;
- Weathers, Allison L.;
- Pohlman, Brad;
- Hill, Brian T.
Publication type:
Article
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 537, doi. 10.1111/ejh.13582
By:
- Sharpley, Faye A.;
- Manwani, Richa;
- Petrie, Aviva;
- Mahmood, Shameem;
- Sachchithanantham, Sajitha;
- Lachmann, Helen J.;
- Martinez De Azcona Naharro, Ana;
- Gillmore, Julian D.;
- Whelan, Carol J.;
- Fontana, Marianna;
- Cohen, Oliver;
- Hawkins, Philip N.;
- Wechalekar, Ashutosh D.
Publication type:
Article
Patterns of previous and secondary malignancies in patients with multiple myeloma.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 529, doi. 10.1111/ejh.13581
By:
- Langseth, Øystein O.;
- Myklebust, Tor Å.;
- Johannesen, Tom B.;
- Hjertner, Øyvind;
- Waage, Anders
Publication type:
Article
Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 439, doi. 10.1111/ejh.13580
By:
- Jolles, Stephen;
- Michallet, Mauricette;
- Agostini, Carlo;
- Albert, Michael H.;
- Edgar, David;
- Ria, Roberto;
- Trentin, Livio;
- Lévy, Vincent
Publication type:
Article
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 520, doi. 10.1111/ejh.13579
By:
- Bartels, Stephan;
- Vogtmann, Julia;
- Schipper, Elisa;
- Büsche, Guntram;
- Schlue, Jerome;
- Lehmann, Ulrich;
- Kreipe, Hans
Publication type:
Article
Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 508, doi. 10.1111/ejh.13576
By:
- Novitzky‐Basso, Igor;
- AlHayli, Saud;
- Shin, Elizabeth;
- Pasic, Ivan;
- Al‐Shaibani, Zeyad;
- Lam, Wilson;
- Law, Arjun;
- Michelis, Fotios V.;
- Gerbitz, Armin;
- Viswabandya, Auro;
- Lipton, Jeffrey H.;
- Kumar, Rajat;
- Mattsson, Jonas;
- Kim, Dennis Dong Hwan
Publication type:
Article
Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 593, doi. 10.1111/ejh.13575
Publication type:
Article
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS‐type molecular findings compared to CCUS without dysplasia.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 500, doi. 10.1111/ejh.13574
By:
- Jajosky, Audrey N.;
- Sadri, Navid;
- Meyerson, Howard J.;
- Oduro, Kwadwo A.;
- Kelkar, Ashwin;
- Fitzgerald, Brynn;
- Tomlinson, Benjamin;
- Moore, Erika M.;
- Beck, Rose C.
Publication type:
Article
Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 493, doi. 10.1111/ejh.13573
By:
- Morabito, Fortunato;
- Tripepi, Giovanni;
- Del Poeta, Giovanni;
- Mauro, Francesca Romana;
- Reda, Gianluigi;
- Sportoletti, Paolo;
- Laurenti, Luca;
- Coscia, Marta;
- Herishanu, Yair;
- Bossio, Sabrina;
- Varettoni, Marzia;
- Murru, Roberta;
- Chiarenza, Annalisa;
- Visentin, Andrea;
- Condoluci, Adalgisa;
- Moia, Riccardo;
- Pietrasanta, Daniela;
- Loseto, Giacomo;
- Consoli, Ugo;
- Scortechini, Ilaria
Publication type:
Article
Comorbidities and complications in adults with pyruvate kinase deficiency.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 484, doi. 10.1111/ejh.13572
By:
- Boscoe, Audra N.;
- Yan, Yan;
- Hedgeman, Elizabeth;
- van Beers, Eduard J.;
- Al‐Samkari, Hanny;
- Barcellini, Wilma;
- Eber, Stefan W.;
- Glader, Bertil;
- Yaish, Hassan M.;
- Chonat, Satheesh;
- Sharma, Mukta;
- Kuo, Kevin H. M.;
- Neufeld, Ellis J.;
- Wang, Heng;
- Verhovsek, Madeleine;
- Sheth, Sujit;
- Grace, Rachael F.
Publication type:
Article
Review of Vitamin B12 deficiency in pregnancy: a diagnosis not to miss as veganism and vegetarianism become more prevalent.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 450, doi. 10.1111/ejh.13571
By:
- Rashid, Sabia;
- Meier, Violet;
- Patrick, Hannah
Publication type:
Article
Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 473, doi. 10.1111/ejh.13569
By:
- Queudeville, Manon;
- Schlegel, Patrick;
- Heinz, Amadeus T.;
- Lenz, Teresa;
- Döring, Michaela;
- Holzer, Ursula;
- Hartmann, Ulrike;
- Kreyenberg, Hermann;
- Stackelberg, Arend;
- Schrappe, Martin;
- Zugmaier, Gerhard;
- Feuchtinger, Tobias;
- Lang, Peter;
- Handgretinger, Rupert;
- Ebinger, Martin
Publication type:
Article
Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 467, doi. 10.1111/ejh.13568
By:
- Van de Wyngaert, Zoé;
- Coppo, Paul;
- Cervera, Pascale;
- Fabiani, Bettina;
- Lemonnier, Marie‐Paule;
- Corre, Elise;
- Marjanovic, Zora;
- Aoudjhane, Malek;
- Mohty, Mohamad;
- Duléry, Rémy
Publication type:
Article
Assessment of von Willebrand disease and pregnancy outcomes at regional Australian hospitals.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 456, doi. 10.1111/ejh.13562
By:
- Wilson, Emily;
- Hanna, Fayez;
- Hyppa, Annemarie;
- Orlowski, Ella;
- Dawar, Hizb U.;
- Sanga, Zar;
- Dennis, Amanda;
- Pavlov, Toly;
- Khalafallah, Alhossain A.
Publication type:
Article
Issue Information.
Published in:
European Journal of Haematology, 2021, v. 106, n. 4, p. 437, doi. 10.1111/ejh.13444
Publication type:
Article